Expression and Role of Myeloid-related Protein-14 in Clinical and Experimental Sepsis
Marieke A. D. van Zoelen(Long Island University), Tom van der Poll(Amsterdam Neuroscience), Sandrine Florquin(Amsterdam University Medical Centers), Thomas Vogl(Goethe University Frankfurt), J. W. Olivier van Till(Astellas Pharma (Netherlands)), Dirk Foell(Klinik für Schlafmedizin), Michael W.T. Tanck(Amsterdam UMC Location University of Amsterdam), Pierre‐François Laterre(Cliniques Universitaires Saint-Luc), Suzanne Q. van Veen(Sanquin), Johannes Roth(University of Münster), Xavier Wittebole(Cliniques Universitaires Saint-Luc), Marja A. Boermeester(Amsterdam University Medical Centers)
American Journal of Respiratory and Critical Care Medicine
September 18, 2009
Cited by 129
Related Papers
The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
|JAMA|2016|28.1k
Efficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis
|New England Journal of Medicine|2001|6.1k
High-Flow Oxygen through Nasal Cannula in Acute Hypoxemic Respiratory Failure
|New England Journal of Medicine|2015|2.4k
Derivation, Validation, and Potential Treatment Implications of Novel Clinical Phenotypes for Sepsis
|JAMA|2019|1.5k
Activated STING in a Vascular and Pulmonary Syndrome
|New England Journal of Medicine|2014|1.4k